Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)
| Market Cap | 183.32M-16.9% |
| Revenue (ttm) | 0 |
| Net Income | -98.56M-773.1% |
| EPS | -0.99+24.1% |
| Shares Out | 77.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 275,842 |
| Open | 2.40 |
| Previous Close | 2.42 |
| Day's Range | 2.36 - 2.40 |
| 52-Week Range | 1.35 - 4.60 |
| Beta | 0.85 |
| Analysts | Buy |
| Price Target | 7.00(+194.74%) |
| Earnings Date | Nov 13, 2026 |
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About ELDN
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, Eledon Pharmaceuticals, Inc., in January 2021. Its corporate headquarters are located in Irvine, California.
$ELDN stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ELDN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ELDN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ELDN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ELDN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ELDN from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ELDN
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $7.40M |
| IWMiShares Russell 2000 ETF | $5.03M |
| VXFVanguard Extended Market ETF | $2.55M |
| IWOiShares Russell 2000 Growth ETF | $1.77M |
| VTWOVanguard Russell 2000 ETF | $1.32M |
| DFASDimensional - US Small Cap ETF | $616.75K |
Estimated from each fund’s disclosed top holdings × AUM
ELDN Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ELDN’s recent data — informational, not investment advice